Oculis Holding AG (OCS) Stock Forecast

NASDAQ: OCSAnalyst ratings, price target and estimates.

OCS analyst forecast

as of October 18, 2026
Analyst consensus
Strong buy
4.70 / 5 from 10 analysts
Price target
$37.00
average of analyst targets
Upside to target
+407.6%
from the latest close
Next earnings
November 9, 2026
EPS estimate $-0.49
52-week range
$7.17 – $32.65

OCS analyst ratings

10 analysts
Strong buy
770%
Buy
330%
Hold
00%
Sell
00%
Strong sell
00%

Number of analysts at each rating.

OCS price target

Price $7.29Target $37.00
52-week low $7.1752-week high $32.65

The average of analyst 12-month price targets compared with the latest close and the 52-week range.

OCS earnings per share estimates

Oculis Holding AG EPS estimates
PeriodAverageLowHighYear agoGrowthAnalysts
Current quarter (Sep '26)−$0.40−$0.48−$0.30−$0.32−24.4%8
Current fiscal year (2026)−$1.56−$1.70−$1.42−$1.89+17.4%7
Next fiscal year (2027)−$1.62−$1.90−$1.33−$1.56−4.0%7

Consensus EPS estimates; growth compares the average estimate with the year-ago EPS.

OCS revenue estimates

Oculis Holding AG revenue estimates
PeriodAverageLowHighGrowthAnalysts
Current quarter (Sep '26)$157,590$0$300,000−35.1%9
Current fiscal year (2026)$878,050$500,000$1.2M−26.8%9
Next fiscal year (2027)$4.1M$0$23.8M+365.2%9

OCS EPS: reported and forecast

Reported EPSEstimate (average; low–high)

Fiscal years; "E" marks estimates, the line shows the range from the lowest to the highest estimate.

OCS revenue: reported and forecast

Reported revenueEstimate (average; low–high)

OCS EPS estimate revisions

Oculis Holding AG EPS estimate revisions
Period90 days ago60 days ago30 days ago7 days agoNowChange (90 d)Revisions (30 d)
Current quarter (Sep '26)−$0.42−$0.40−$0.40−$0.40−$0.40−4.4%2 up · 2 down
Current fiscal year (2026)−$1.79−$1.60−$1.56−$1.56−$1.56−12.9%5 up · 1 down
Next fiscal year (2027)−$1.64−$1.66−$1.65−$1.65−$1.62−0.8%2 up · 3 down

How the consensus EPS estimate changed over the last 90 days, and how many analysts raised or lowered it in the last 30 days.

OCS earnings surprises

Reported EPSEstimate

Reported EPS vs the consensus estimate for the last 12 quarters; OCS beat in 3 of 12.

What analysts expect from OCS

10 analysts cover Oculis; their consensus rating is strong buy (4.70 on a 1–5 scale, where 5 is a strong buy). The average price target is $37.00, 407.6% above the latest close of $7.29. Analysts expect earnings of −$1.56 per share for 2026, +17.4% from a year earlier. For 2027 the average estimate is −$1.62 per share on revenue of $4.1 million. Oculis beat the EPS estimate in 3 of the last 12 quarters.

Related: OCS income statement, OCS key metrics, OCS chart. See the OCS stock overview for the latest quote and news.

OCS forecast FAQ

What is Oculis's price target?

The average analyst price target for Oculis is $37.00, 407.6% above the latest close of $7.29.

Is Oculis a buy, hold or sell?

Of 10 analysts covering Oculis, 7 rate it a strong buy, 3 a buy, 0 a hold, 0 a sell and 0 a strong sell, a consensus of strong buy. Ratings are opinions, not a recommendation from Quotelinks.

What is Oculis's EPS forecast?

Analysts forecast −$1.56 per share for 2026 (range −$1.70 to −$1.42); for 2027 the estimate is −$1.62.

What is Oculis's revenue forecast?

The average revenue estimate for 2026 is $0.9 million, growth of −26.8%; for 2027 it is $4.1 million.

When does Oculis report earnings?

Oculis is expected to report results for the quarter ending September 30, 2026 on November 9, 2026; the EPS estimate is $-0.49.

Does Oculis usually beat earnings estimates?

Oculis reported EPS at or above the analyst estimate in 3 of the last 12 quarters.

Biotechnology: forecast